CMS ACCESS Model API
0.9.12 - draft
CMS ACCESS Model API
0.9.12 - draft
This page is part of the ACCESS Model IG v0.9.12 DRAFT (v0.9.12: Releases Draft) based on FHIR (HL7® FHIR® Standard) R4. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
| Active as of 2026-06-10 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="ACCESSeCKMDiagnosisVS"/>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet ACCESSeCKMDiagnosisVS</b></p><a name="ACCESSeCKMDiagnosisVS"> </a><a name="hcACCESSeCKMDiagnosisVS"> </a><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.2.0/CodeSystem-icd10CM.html"><code>http://hl7.org/fhir/sid/icd-10-cm</code></a><span title="Version is not explicitly stated. No matching Code System found"> version Not Stated (use latest from terminology server)</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>E66.01</td><td>Morbid (severe) obesity due to excess calories</td></tr><tr><td>E66.09</td><td>Other obesity due to excess calories</td></tr><tr><td>E66.1</td><td>Drug-induced obesity</td></tr><tr><td>E66.2</td><td>Morbid (severe) obesity with alveolar hypoventilation</td></tr><tr><td>E66.3</td><td>Overweight</td></tr><tr><td>E66.811</td><td>Obesity, class 1</td></tr><tr><td>E66.812</td><td>Obesity, class 2</td></tr><tr><td>E66.813</td><td>Obesity, class 3</td></tr><tr><td>E66.89</td><td>Other obesity not elsewhere classified</td></tr><tr><td>E66.9</td><td>Obesity, unspecified</td></tr><tr><td>E78.00</td><td>Pure hypercholesterolemia, unspecified</td></tr><tr><td>E78.010</td><td>Homozygous familial hypercholesterolemia [HoFH]</td></tr><tr><td>E78.011</td><td>Heterozygous familial hypercholesterolemia [HeFH]</td></tr><tr><td>E78.019</td><td>Familial hypercholesterolemia, unspecified</td></tr><tr><td>E78.1</td><td>Pure hyperglyceridemia</td></tr><tr><td>E78.2</td><td>Mixed hyperlipidemia</td></tr><tr><td>E78.3</td><td>Hyperchylomicronemia</td></tr><tr><td>E78.41</td><td>Elevated Lipoprotein(a)</td></tr><tr><td>E78.49</td><td>Other hyperlipidemia</td></tr><tr><td>E78.5</td><td>Hyperlipidemia, unspecified</td></tr><tr><td>E78.6</td><td>Lipoprotein deficiency</td></tr><tr><td>E78.70</td><td>Disorder of bile acid and cholesterol metabolism, unspecified</td></tr><tr><td>E78.71</td><td>Barth syndrome</td></tr><tr><td>E78.72</td><td>Smith-Lemli-Opitz syndrome</td></tr><tr><td>E78.79</td><td>Other disorders of bile acid and cholesterol metabolism</td></tr><tr><td>E78.81</td><td>Lipoid dermatoarthritis</td></tr><tr><td>E78.89</td><td>Other lipoprotein metabolism disorders</td></tr><tr><td>E78.9</td><td>Disorder of lipoprotein metabolism, unspecified</td></tr><tr><td>I10</td><td>Essential (primary) hypertension</td></tr><tr><td>I11.0</td><td>Hypertensive heart disease with heart failure</td></tr><tr><td>I11.9</td><td>Hypertensive heart disease without heart failure</td></tr><tr><td>I12.9</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td></tr><tr><td>I13.0</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td></tr><tr><td>I13.10</td><td>Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td></tr><tr><td>I15.0</td><td>Renovascular hypertension</td></tr><tr><td>I15.1</td><td>Hypertension secondary to other renal disorders</td></tr><tr><td>I15.2</td><td>Hypertension secondary to endocrine disorders</td></tr><tr><td>I15.8</td><td>Other secondary hypertension</td></tr><tr><td>I15.9</td><td>Secondary hypertension, unspecified</td></tr><tr><td>I1A.0</td><td>Resistant hypertension</td></tr><tr><td>R73.01</td><td>Impaired fasting glucose</td></tr><tr><td>R73.02</td><td>Impaired glucose tolerance (oral)</td></tr><tr><td>R73.03</td><td>Prediabetes</td></tr><tr><td>R73.09</td><td>Other abnormal glucose</td></tr><tr><td>R73.9</td><td>Hyperglycemia, unspecified</td></tr></table></li></ul></div>
</text>
<url
value="https://dsacms.github.io/cmmi-access-model/ValueSet/ACCESSeCKMDiagnosisVS"/>
<version value="0.9.12"/>
<name value="ACCESSeCKMDiagnosisVS"/>
<title
value="ACCESS Early Cardio-Kidney-Metabolic (eCKM) Track Qualifying Diagnoses"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-06-10T23:08:55-04:00"/>
<publisher value="Global Alliant, Inc."/>
<contact>
<name value="Global Alliant, Inc."/>
<telecom>
<system value="url"/>
<value value="https://globalalliantinc.com"/>
</telecom>
<telecom>
<system value="email"/>
<value value="david.h@globalalliantinc.org"/>
</telecom>
</contact>
<description
value="This value set contains ICD-10-CM diagnosis codes that qualify a patient for the ACCESS Model Early Cardio-Kidney-Metabolic (eCKM) track. Includes hypertension, dyslipidemia, prediabetes, and obesity diagnoses."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="US"/>
<display value="United States of America"/>
</coding>
</jurisdiction>
<copyright
value="This value set includes content from ICD-10-CM, which is copyright World Health Organization (WHO). ICD-10-CM codes are freely available in the public domain."/>
<compose>
<include>
<system value="http://hl7.org/fhir/sid/icd-10-cm"/>
<concept>
<code value="E66.01"/>
<display value="Morbid (severe) obesity due to excess calories"/>
</concept>
<concept>
<code value="E66.09"/>
<display value="Other obesity due to excess calories"/>
</concept>
<concept>
<code value="E66.1"/>
<display value="Drug-induced obesity"/>
</concept>
<concept>
<code value="E66.2"/>
<display
value="Morbid (severe) obesity with alveolar hypoventilation"/>
</concept>
<concept>
<code value="E66.3"/>
<display value="Overweight"/>
</concept>
<concept>
<code value="E66.811"/>
<display value="Obesity, class 1"/>
</concept>
<concept>
<code value="E66.812"/>
<display value="Obesity, class 2"/>
</concept>
<concept>
<code value="E66.813"/>
<display value="Obesity, class 3"/>
</concept>
<concept>
<code value="E66.89"/>
<display value="Other obesity not elsewhere classified"/>
</concept>
<concept>
<code value="E66.9"/>
<display value="Obesity, unspecified"/>
</concept>
<concept>
<code value="E78.00"/>
<display value="Pure hypercholesterolemia, unspecified"/>
</concept>
<concept>
<code value="E78.010"/>
<display value="Homozygous familial hypercholesterolemia [HoFH]"/>
</concept>
<concept>
<code value="E78.011"/>
<display value="Heterozygous familial hypercholesterolemia [HeFH]"/>
</concept>
<concept>
<code value="E78.019"/>
<display value="Familial hypercholesterolemia, unspecified"/>
</concept>
<concept>
<code value="E78.1"/>
<display value="Pure hyperglyceridemia"/>
</concept>
<concept>
<code value="E78.2"/>
<display value="Mixed hyperlipidemia"/>
</concept>
<concept>
<code value="E78.3"/>
<display value="Hyperchylomicronemia"/>
</concept>
<concept>
<code value="E78.41"/>
<display value="Elevated Lipoprotein(a)"/>
</concept>
<concept>
<code value="E78.49"/>
<display value="Other hyperlipidemia"/>
</concept>
<concept>
<code value="E78.5"/>
<display value="Hyperlipidemia, unspecified"/>
</concept>
<concept>
<code value="E78.6"/>
<display value="Lipoprotein deficiency"/>
</concept>
<concept>
<code value="E78.70"/>
<display
value="Disorder of bile acid and cholesterol metabolism, unspecified"/>
</concept>
<concept>
<code value="E78.71"/>
<display value="Barth syndrome"/>
</concept>
<concept>
<code value="E78.72"/>
<display value="Smith-Lemli-Opitz syndrome"/>
</concept>
<concept>
<code value="E78.79"/>
<display
value="Other disorders of bile acid and cholesterol metabolism"/>
</concept>
<concept>
<code value="E78.81"/>
<display value="Lipoid dermatoarthritis"/>
</concept>
<concept>
<code value="E78.89"/>
<display value="Other lipoprotein metabolism disorders"/>
</concept>
<concept>
<code value="E78.9"/>
<display value="Disorder of lipoprotein metabolism, unspecified"/>
</concept>
<concept>
<code value="I10"/>
<display value="Essential (primary) hypertension"/>
</concept>
<concept>
<code value="I11.0"/>
<display value="Hypertensive heart disease with heart failure"/>
</concept>
<concept>
<code value="I11.9"/>
<display value="Hypertensive heart disease without heart failure"/>
</concept>
<concept>
<code value="I12.9"/>
<display
value="Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
</concept>
<concept>
<code value="I13.0"/>
<display
value="Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
</concept>
<concept>
<code value="I13.10"/>
<display
value="Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
</concept>
<concept>
<code value="I15.0"/>
<display value="Renovascular hypertension"/>
</concept>
<concept>
<code value="I15.1"/>
<display value="Hypertension secondary to other renal disorders"/>
</concept>
<concept>
<code value="I15.2"/>
<display value="Hypertension secondary to endocrine disorders"/>
</concept>
<concept>
<code value="I15.8"/>
<display value="Other secondary hypertension"/>
</concept>
<concept>
<code value="I15.9"/>
<display value="Secondary hypertension, unspecified"/>
</concept>
<concept>
<code value="I1A.0"/>
<display value="Resistant hypertension"/>
</concept>
<concept>
<code value="R73.01"/>
<display value="Impaired fasting glucose"/>
</concept>
<concept>
<code value="R73.02"/>
<display value="Impaired glucose tolerance (oral)"/>
</concept>
<concept>
<code value="R73.03"/>
<display value="Prediabetes"/>
</concept>
<concept>
<code value="R73.09"/>
<display value="Other abnormal glucose"/>
</concept>
<concept>
<code value="R73.9"/>
<display value="Hyperglycemia, unspecified"/>
</concept>
</include>
</compose>
</ValueSet>